AUD 0.01
(-6.67%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.78 Million AUD | 49.21% |
2022 | 4.27 Million USD | -13.57% |
2021 | 4.94 Million AUD | 6.38% |
2020 | 4.64 Million AUD | 6.96% |
2019 | 4.34 Million AUD | 54.22% |
2018 | 2.81 Million AUD | 239.63% |
2017 | 829.72 Thousand AUD | -69.34% |
2016 | 2.7 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 3.25 Million AUD | 0.0% |
2023 Q2 | 3.15 Million AUD | 0.0% |
2023 FY | 6.37 Million AUD | 49.21% |
2023 Q4 | 3.21 Million AUD | 0.0% |
2022 Q2 | 1.95 Million AUD | 0.0% |
2022 Q4 | 2.32 Million AUD | 0.0% |
2022 FY | 4.27 Million USD | -13.57% |
2021 FY | 4.94 Million AUD | 6.38% |
2021 Q4 | 2.84 Million AUD | 0.0% |
2021 Q2 | 2.11 Million AUD | 0.0% |
2020 Q4 | 2.6 Million AUD | 0.0% |
2020 FY | 4.64 Million AUD | 6.96% |
2020 Q2 | 2 Million AUD | 0.0% |
2019 FY | 4.34 Million AUD | 54.22% |
2019 Q4 | 2.38 Million AUD | 0.0% |
2019 Q2 | 1.96 Million AUD | 0.0% |
2018 Q4 | 291.16 Thousand AUD | 0.0% |
2018 FY | 2.81 Million AUD | 239.63% |
2018 Q2 | 998.15 Thousand AUD | 0.0% |
2018 Q1 | 998.15 Thousand AUD | 0.0% |
2017 FY | 829.72 Thousand AUD | -69.34% |
2017 Q4 | 998.15 Thousand AUD | 0.0% |
2016 FY | 2.7 Million AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 78.456% |
Adherium Limited | 267.7 Thousand AUD | -2433.762% |
Aroa Biosurgery Limited | 66.09 Million AUD | 89.738% |
Atomo Diagnostics Limited | 1.6 Million AUD | -322.35% |
Anteris Technologies Ltd | 69.14 Million AUD | 90.191% |
Control Bionics Limited | 9.82 Million AUD | 30.969% |
CardieX Limited | 16.64 Million AUD | 59.259% |
Compumedics Limited | 26.88 Million AUD | 74.766% |
Cochlear Limited | 1.17 Billion AUD | 99.423% |
CleanSpace Holdings Limited | 11.35 Million AUD | 40.287% |
Cyclopharm Limited | 13.38 Million AUD | 49.308% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 47.147% |
Nova Eye Medical Limited | 23.99 Million AUD | 71.726% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 707.88% |
ImpediMed Limited | 28.04 Million AUD | 75.811% |
InhaleRx Limited | 2.59 Million AUD | -161.836% |
LBT Innovations Limited | 1.1 Million AUD | -512.733% |
Micro-X Limited | 18.76 Million AUD | 63.851% |
Neurotech International Limited | 8.75 Million AUD | 22.519% |
OncoSil Medical Limited | 12.03 Million AUD | 43.662% |
PolyNovo Limited | 34.92 Million AUD | 80.577% |
Respiri Limited | 8.03 Million AUD | 15.581% |
SomnoMed Limited | 58.97 Million AUD | 88.498% |
Universal Biosensors, Inc. | 20 Million AUD | 66.086% |
Uscom Limited | 5.52 Million AUD | -22.879% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 29.591% |